Search results
Evidence suggests lungs as the organ most affected by coronavirus disease 2019 (COVID-19). The literature on previous coronavirus infections reports that patients may experience persistent impairment in respiratory function after being discharged.
7 mar 2022 · This international statement presents the consensus opinion of 23 experts in the field of lung function and respiratory physiology balanced with evidence from the reviewed literature. It describes a robust roadmap for restoration and continuity of lung function testing services during the COVID-19 pandemic and beyond.
26 mar 2021 · 60 days after COVID-19 onset, 42% of patients demonstrated abnormal lung function — most common was a reduced DLco. After 100 days of COVID-19 onset, 41% of patients exhibited persistent symptoms and 36% had abnormal lung function findings; DLco had improved in 30% of patients that were abnormal at 60 days
29 maj 2020 · Central to planning in this phase are the precautions needed to protect lung function staff, and to minimise cross-infection risk, given an ongoing need to test vulnerable patient groups—eg, immunocompromised or individuals with long-term conditions.
8 cze 2021 · The primary goal of this manuscript is to develop a computer assisted diagnostic (CAD) system to assess pulmonary function and risk of mortality in patients with coronavirus disease 2019...
23 mar 2023 · Interpretation. 129 Xe gas transfer was impaired up to 1 year following hospitalization in patients who were hospitalized with COVID-19 pneumonia, without evidence of architectural distortion on structural imaging, whereas lung ventilation was normal at 52 weeks.
This information should aid clinicians in their interpretation of pulmonary function tests obtained following COVID-19 infection. Funding: No funding was obtained for this study. 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/) 1.
